Zapnometinib
Zapnometinib (ATR-002) is a selective small molecule inhibitor targeting the MEK kinase. It is utilized in biochemical and cellular research to investigate MAPK/ERK pathway signaling and has been studied in preclinical models for its potential therapeutic effects.
Product Specifications
CAS Number
303175-44-2
Product Name Alternative
CI-1040, antiviral, antibacterial, ATR 002, ATR002, ATR-002, Bacterial, 3,4-difluoro-2- (2-chloro-4-iodophenylaMino) -benzoic acid, 2- (2-chloro-4-iodoanilino) -3,4-difluorobenzoic acid, MEK, MAPKK, MAP2K, Inhibitor, inhibit, influenza, Influenza Virus, InfluenzaVirus, PD 0184264, PD0184264, PD-0184264, Mitogen-activated protein kinase kinase, zapnometinib, virus
Field of Research
Infectious Disease & Virology, Signal Transduction
Purity
99.66% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (4.88 mM) ; DMSO:60 mg/mL (146.5 mM)
Smiles
OC (=O) c1ccc (F) c (F) c1Nc1ccc (I) cc1Cl
Molecular Formula
C13H7ClF2INO2
Molecular Weight
409.55
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
K2571806 1.0 µg DNA
UBE2F sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 1)
Sign In for Pricing
View Details 
MBS2166314-01 0.1 mL
Cy3-Linked Monoclonal Antibody to Immunoglobulin G (IgG)
Sign In for Pricing
View Details